Investing.comQwen · 实盘不做把握 3/10不做原因:已被定价
北京时间·🕒 发布 08-26 23:00:55·⟳ 抓取 08-26 23:02:28 +1m33s·⚡ 决策 08-27 08:28:42 +9h26m·61.8 天前
Donaldson FY2026 Q4营收首破10亿美元、EPS小幅超预期,但FY2027指引中值低于共识
Q4 EPS/营收beat幅度仅约+1.8%,已在当日盘中被完全消化(股价+2.12%);更关键的是FY2027 EPS指引中值$4.30低于共识$4.41,前瞻信号偏负面。自家案例库显示同一事件已被处理两次且均判定不做。美股已收盘,无剩余可执行窗口。
📄 原文Investing.com↗ 原文
Donaldson Q4 FY26 slides: record $1B+ sales, 17.5% margins
Oil prices slide amid hopes for progress in Mideast diplomacy Introduction & Market Context Donaldson Company (NYSE:DCI…
不做 Donaldson Company(DCI.US)
Q4 beat幅度仅+1.8%已在盘中完全消化(+2.12%);FY2027 EPS指引中值$4.30低于共识$4.41,前瞻信号偏负面;自家系统同日已两次处理同一事件均判不做;美股已收盘无剩余可执行窗口,次日追多无正期望。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Donaldson Q4 FY26财报营收首破$10亿、EPS $1.15小幅超预期(+1.8%),当日股价已涨+2.12%完成定价。FY2027全年EPS指引中值$4.30低于市场共识$4.41,前瞻预期实际偏负面。事件已在盘中被消化,且指引不及共识意味着追多无正期望。自家系统同日已两次处理同一事件均判不做。
🔎 新鲜度:最早出现 2026-08-26 · 扩散 high · price-in 风险 high ↗
消息传播链
- Investing.com AI生成文章报道Q4财报,非一手披露但时间戳与财报发布一致市场反应:DCI当日收盘$95.24,+2.12%
主要风险
- FY2027 EPS指引中值$4.30低于共识$4.41,若分析师下修预期可能带来后续压力
反向证据
- 做多前查反向 · 来源 kb_search · 日期 2026-08-26 · 影响 invalidates
自家案例库记录显示FY2027 EPS指引中值$4.30低于共识$4.41,构成做多反证
检索:Donaldson FY2027 guidance vs consensus
先例如何影响了这次决策
对本次决策的影响:先例不足不改变结论:本次事件已被盘中消化且指引低于共识,无论先例如何都不构成做多理由
方向:无法建立有效先例面板
涨幅量级:无高相似先例可用于校准幅度
形态:无法判断
工具调用 · 历史记录,结果未知(5 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
- stock_quote · 结果未知
- search_case_library · 结果未知
- web_search · 结果未知
原文全文
展开原文 · 12,802 字
Oil prices slide amid hopes for progress in Mideast diplomacy
Introduction & Market Context
Donaldson Company (NYSE:DCI) presented its fourth quarter fiscal year 2026 results on August 26, 2026, marking a historic milestone with quarterly sales exceeding $1 billion for the first time in company history. The filtration solutions provider delivered adjusted earnings per share of $1.15 on revenue of $1.059 billion, surpassing analyst expectations of $1.13 per share on sales of $1.04 billion. The stock rose 2.31% to $95.41 following the announcement, reflecting investor confidence in the company’s execution and forward guidance.
The presentation highlighted Donaldson’s position as a leader in filtration technology across three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. Management emphasized the company’s strategic focus on expanding leadership in legacy markets while penetrating new growth opportunities, particularly in sustainability-driven applications and life sciences.
Executive Summary
As outlined in the company’s presentation overview, Donaldson achieved several key milestones in the fourth quarter that positioned the business for continued growth. The quarter represented the culmination of a record fiscal year, with all-time highs in sales, adjusted operating margin, and adjusted earnings.
Management highlighted three primary achievements: delivering robust execution across all three segments, maintaining expense discipline to drive operating leverage, and successfully integrating the Facet acquisition while paying down $102 million of related debt. The company returned $37 million to shareholders through dividends in the quarter, bringing full-year shareholder returns to $250 million through dividends and share repurchases.
The presentation emphasized Donaldson’s role as an enabler of the modern green economy, helping customers achieve sustainability goals through advanced filtration solutions. This positioning aligns with growing regulatory requirements and customer demand for environmental solutions across industrial and mobile applications.
Quarterly Performance Highlights
The fourth quarter demonstrated strong momentum across key financial metrics, with the company achieving record adjusted operating margins of 17.5%, an improvement of 110 basis points year-over-year. This performance was driven by higher volume, favorable pricing, and improved mix, partially offset by input cost inflation and operational inefficiencies in certain areas.
The following chart illustrates the quarterly performance across three critical metrics:
Sales growth of 8% year-over-year reflected contributions from all three segments, with pricing adding approximately 2 percentage points and the Facet acquisition contributing 3 percentage points. On a constant currency basis, sales increased 7%, indicating solid underlying organic growth momentum.
Adjusted gross margin expanded significantly to 36.7%, up 190 basis points from the prior year period. This improvement was attributed to volume leverage, pricing actions, and favorable product mix, particularly from stronger aftermarket sales in Mobile Solutions and higher-margin businesses in Life Sciences. However, adjusted operating expenses as a percentage of sales increased 80 basis points, reflecting investments in growth initiatives and Facet integration costs.
Adjusted diluted earnings per share of $1.15 represented a 12% increase from $1.03 in the prior year quarter, with adjusted operating income growing 15% year-over-year. Free cash flow conversion reached an impressive 136%, supported by efficient working capital management.
Full-Year Fiscal 2026 Performance
For the complete fiscal year 2026, Donaldson reported sales of $3.886 billion, representing 5% growth year-over-year and 3% growth on a constant currency basis. The company achieved record adjusted operating margins of 16.0%, expanding 30 basis points from the prior year despite headwinds in certain industrial operations.
The full-year performance is illustrated in the following comparison:
Adjusted diluted earnings per share reached $3.98, an 8% increase from $3.68 in fiscal 2025. The earnings growth outpaced sales growth, demonstrating the company’s ability to drive operating leverage through pricing discipline and operational improvements. Segment performance varied, with Mobile Solutions growing 6%, Industrial Solutions advancing 3%, and Life Sciences delivering strong 13% growth.
Adjusted gross margin for the year improved 10 basis points despite operational inefficiencies in the Industrial segment, while adjusted operating expenses as a percentage of sales decreased 20 basis points due to continued expense discipline. This combination enabled the company to expand operating margins while investing in strategic growth initiatives.
Segment Analysis
Mobile Solutions
The Mobile Solutions segment, Donaldson’s largest business, delivered strong fourth quarter results with sales of $635 million, up 8% year-over-year. Segment earnings before tax reached $136 million, representing a 21% increase and a margin of 21.3%, up 220 basis points from the prior year.
The segment’s performance was driven by robust aftermarket sales growth across all regions and both OE and independent channels. On-road sales increased due to truck production ramps, particularly in the US and Europe, while off-road sales remained flat as construction growth offset muted agriculture performance. Regional performance showed particular strength in APAC (+14%) and US/Canada (+9%), with more modest growth in EMEA (+3%) and LATAM (+9%).
The significant margin expansion reflected volume leverage, pricing benefits, and favorable mix from strong aftermarket sales, which typically carry higher margins than original equipment sales. This performance underscores the resilience of Donaldson’s aftermarket business model and the mission-critical nature of filtration products.
Industrial Solutions
Industrial Solutions reported fourth quarter sales of $334 million, up 8% year-over-year, but segment earnings before tax declined 15% to $55 million. The segment margin contracted 450 basis points to 16.4%, reflecting integration challenges and operational headwinds.
The sales increase was driven primarily by the inclusion of Facet, which contributed significantly to the Aerospace and Defense business. Organic Industrial Filtration Solutions sales decreased due to lower dust collection new equipment volumes, though this was partially offset by robust Power Generation new equipment sales. Aerospace and Defense sales increased 61% year-over-year with Facet included, though organic Aerospace and Defense sales declined due to ongoing supply chain issues.
The margin contraction resulted from Facet run-rate expenses, organic expense deleveraging, and headwinds associated with Power Generation production shifts. Management indicated these challenges are temporary, with improvements expected by mid-fiscal 2027 as production transitions stabilize and Facet integration progresses.
Life Sciences
The Life Sciences segment delivered exceptional fourth quarter results, with sales of $90 million up 10% year-over-year and earnings before tax of $11 million, representing a margin of 11.9%, up 660 basis points from 5.3% in the prior year.
The strong performance was driven by double-digit growth in Disk Drive and solid Food and Beverage new equipment sales. Regional performance showed strength in EMEA (+14%), APAC (+10%), and LATAM (+7%), with US/Canada down slightly (-1%).
The dramatic margin expansion of 660 basis points was attributed to volume leverage from higher-margin Food and Beverage and Disk Drive businesses, combined with continued expense discipline. Management announced the segment will be renamed "Process Filtration" beginning in the first quarter of fiscal 2027, reflecting its broader portfolio beyond traditional life sciences applications.
Strategic Initiatives
The presentation emphasized five key strategic pillars supporting Donaldson’s investment thesis. These include the company’s leadership position in filtration, best-in-class technology capabilities, role as an enabler of a greener economy, clear and balanced growth strategy, and progress toward Life Sciences market leadership.
The Facet acquisition represents a significant strategic initiative, adding capabilities in aerospace and defense filtration while providing favorable mix benefits to enterprise gross margin. In the fourth quarter alone, Donaldson paid down $102 million of Facet-related debt, demonstrating strong cash generation and commitment to deleveraging. Net debt to adjusted EBITDA stood at 1.4x at fiscal year-end, up from 0.7x in the prior year due to the acquisition, but on a trajectory toward the company’s target leverage range.
Management highlighted continued investment in technology and organizational capabilities to strengthen long-term profitable growth. The strategic organizational redesign mentioned in the presentation aims to enhance the company’s ability to drive innovation and respond to evolving customer needs across diverse end markets.
Financial Position and Cash Flow
Donaldson’s balance sheet and cash flow performance demonstrated the company’s financial strength and disciplined capital allocation. Adjusted free cash flow conversion reached 136% in the fourth quarter and 91% for the full fiscal year, supported by efficient working capital management.
Cash from operations totaled $200 million in the fourth quarter and $494 million for the full year, representing increases of 19% and 18% respectively versus the prior year. Net capital expenditures of $15 million in the quarter and $57 million for the year reflected disciplined investment in capacity and capabilities while maintaining capital efficiency.
The company’s net debt position increased to $1.074 billion from $488 million in the prior year, primarily due to the Facet acquisition. However, the net debt to adjusted EBITDA ratio of 1.4x remains manageable, and management demonstrated commitment to deleveraging through the $102 million debt paydown in the fourth quarter. Total debt stood at $1.325 billion against cash and cash equivalents of $250 million.
Donaldson returned $37 million to shareholders through dividends in the fourth quarter, with no share repurchases during the period. For the full fiscal year, the company returned $250 million to shareholders through $141 million in dividends and $109 million in share buybacks, demonstrating balanced capital allocation between debt reduction, growth investments, and shareholder returns.
Forward-Looking Statements
Management issued fiscal 2027 guidance projecting continued growth across all segments and further margin expansion. The company expects sales growth of 5.5% to 9.5%, centered on approximately $4.2 billion, with adjusted operating margins ranging from 16.6% to 17.2%.
Diluted earnings per share guidance of $4.22 to $4.38 brackets $4.30 at the midpoint, representing approximately 8% growth from fiscal 2026 adjusted EPS of $3.98. This guidance reflects contributions from organic growth, pricing, the Facet acquisition, and currency benefits, partially offset by integration costs and normal seasonality.
By segment, Mobile Solutions is expected to grow 2% to 6%, with off-road up mid-single digits, on-road up high-single digits, and aftermarket up mid-single digits. Industrial Solutions projects mid-teens growth, with approximately half coming from Facet and the remainder from mid-teens organic growth in Aerospace and Defense and mid-single digit growth in Industrial Filtration Solutions. Life Sciences anticipates 7% to 11% growth, continuing its strong momentum.
The guidance assumes a tax rate of 23.5% to 25.5%, pricing benefit of approximately 2%, Facet sales benefit of approximately 2%, interest expense of $55 million to $60 million, and foreign currency benefit of 1%. Capital expenditures are projected at $70 million to $90 million, with free cash flow conversion of 95% to 105%.
Management noted that the second half of fiscal 2027 should account for approximately 52% of sales and 57% of operating profit, reflecting normal seasonality patterns. The company expects power generation operational issues to improve by mid-fiscal 2027 as production transitions stabilize, providing a tailwind to Industrial Solutions margins in the back half of the year.
The fiscal 2027 outlook represents record guidance for Donaldson, building on the momentum from fiscal 2026 and positioning the company for sustained profitable growth across its diversified portfolio of filtration solutions.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Introduction & Market Context
Donaldson Company (NYSE:DCI) presented its fourth quarter fiscal year 2026 results on August 26, 2026, marking a historic milestone with quarterly sales exceeding $1 billion for the first time in company history. The filtration solutions provider delivered adjusted earnings per share of $1.15 on revenue of $1.059 billion, surpassing analyst expectations of $1.13 per share on sales of $1.04 billion. The stock rose 2.31% to $95.41 following the announcement, reflecting investor confidence in the company’s execution and forward guidance.
The presentation highlighted Donaldson’s position as a leader in filtration technology across three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. Management emphasized the company’s strategic focus on expanding leadership in legacy markets while penetrating new growth opportunities, particularly in sustainability-driven applications and life sciences.
Executive Summary
As outlined in the company’s presentation overview, Donaldson achieved several key milestones in the fourth quarter that positioned the business for continued growth. The quarter represented the culmination of a record fiscal year, with all-time highs in sales, adjusted operating margin, and adjusted earnings.
Management highlighted three primary achievements: delivering robust execution across all three segments, maintaining expense discipline to drive operating leverage, and successfully integrating the Facet acquisition while paying down $102 million of related debt. The company returned $37 million to shareholders through dividends in the quarter, bringing full-year shareholder returns to $250 million through dividends and share repurchases.
The presentation emphasized Donaldson’s role as an enabler of the modern green economy, helping customers achieve sustainability goals through advanced filtration solutions. This positioning aligns with growing regulatory requirements and customer demand for environmental solutions across industrial and mobile applications.
Quarterly Performance Highlights
The fourth quarter demonstrated strong momentum across key financial metrics, with the company achieving record adjusted operating margins of 17.5%, an improvement of 110 basis points year-over-year. This performance was driven by higher volume, favorable pricing, and improved mix, partially offset by input cost inflation and operational inefficiencies in certain areas.
The following chart illustrates the quarterly performance across three critical metrics:
Sales growth of 8% year-over-year reflected contributions from all three segments, with pricing adding approximately 2 percentage points and the Facet acquisition contributing 3 percentage points. On a constant currency basis, sales increased 7%, indicating solid underlying organic growth momentum.
Adjusted gross margin expanded significantly to 36.7%, up 190 basis points from the prior year period. This improvement was attributed to volume leverage, pricing actions, and favorable product mix, particularly from stronger aftermarket sales in Mobile Solutions and higher-margin businesses in Life Sciences. However, adjusted operating expenses as a percentage of sales increased 80 basis points, reflecting investments in growth initiatives and Facet integration costs.
Adjusted diluted earnings per share of $1.15 represented a 12% increase from $1.03 in the prior year quarter, with adjusted operating income growing 15% year-over-year. Free cash flow conversion reached an impressive 136%, supported by efficient working capital management.
Full-Year Fiscal 2026 Performance
For the complete fiscal year 2026, Donaldson reported sales of $3.886 billion, representing 5% growth year-over-year and 3% growth on a constant currency basis. The company achieved record adjusted operating margins of 16.0%, expanding 30 basis points from the prior year despite headwinds in certain industrial operations.
The full-year performance is illustrated in the following comparison:
Adjusted diluted earnings per share reached $3.98, an 8% increase from $3.68 in fiscal 2025. The earnings growth outpaced sales growth, demonstrating the company’s ability to drive operating leverage through pricing discipline and operational improvements. Segment performance varied, with Mobile Solutions growing 6%, Industrial Solutions advancing 3%, and Life Sciences delivering strong 13% growth.
Adjusted gross margin for the year improved 10 basis points despite operational inefficiencies in the Industrial segment, while adjusted operating expenses as a percentage of sales decreased 20 basis points due to continued expense discipline. This combination enabled the company to expand operating margins while investing in strategic growth initiatives.
Segment Analysis
Mobile Solutions
The Mobile Solutions segment, Donaldson’s largest business, delivered strong fourth quarter results with sales of $635 million, up 8% year-over-year. Segment earnings before tax reached $136 million, representing a 21% increase and a margin of 21.3%, up 220 basis points from the prior year.
The segment’s performance was driven by robust aftermarket sales growth across all regions and both OE and independent channels. On-road sales increased due to truck production ramps, particularly in the US and Europe, while off-road sales remained flat as construction growth offset muted agriculture performance. Regional performance showed particular strength in APAC (+14%) and US/Canada (+9%), with more modest growth in EMEA (+3%) and LATAM (+9%).
The significant margin expansion reflected volume leverage, pricing benefits, and favorable mix from strong aftermarket sales, which typically carry higher margins than original equipment sales. This performance underscores the resilience of Donaldson’s aftermarket business model and the mission-critical nature of filtration products.
Industrial Solutions
Industrial Solutions reported fourth quarter sales of $334 million, up 8% year-over-year, but segment earnings before tax declined 15% to $55 million. The segment margin contracted 450 basis points to 16.4%, reflecting integration challenges and operational headwinds.
The sales increase was driven primarily by the inclusion of Facet, which contributed significantly to the Aerospace and Defense business. Organic Industrial Filtration Solutions sales decreased due to lower dust collection new equipment volumes, though this was partially offset by robust Power Generation new equipment sales. Aerospace and Defense sales increased 61% year-over-year with Facet included, though organic Aerospace and Defense sales declined due to ongoing supply chain issues.
The margin contraction resulted from Facet run-rate expenses, organic expense deleveraging, and headwinds associated with Power Generation production shifts. Management indicated these challenges are temporary, with improvements expected by mid-fiscal 2027 as production transitions stabilize and Facet integration progresses.
Life Sciences
The Life Sciences segment delivered exceptional fourth quarter results, with sales of $90 million up 10% year-over-year and earnings before tax of $11 million, representing a margin of 11.9%, up 660 basis points from 5.3% in the prior year.
The strong performance was driven by double-digit growth in Disk Drive and solid Food and Beverage new equipment sales. Regional performance showed strength in EMEA (+14%), APAC (+10%), and LATAM (+7%), with US/Canada down slightly (-1%).
The dramatic margin expansion of 660 basis points was attributed to volume leverage from higher-margin Food and Beverage and Disk Drive businesses, combined with continued expense discipline. Management announced the segment will be renamed "Process Filtration" beginning in the first quarter of fiscal 2027, reflecting its broader portfolio beyond traditional life sciences applications.
Strategic Initiatives
The presentation emphasized five key strategic pillars supporting Donaldson’s investment thesis. These include the company’s leadership position in filtration, best-in-class technology capabilities, role as an enabler of a greener economy, clear and balanced growth strategy, and progress toward Life Sciences market leadership.
The Facet acquisition represents a significant strategic initiative, adding capabilities in aerospace and defense filtration while providing favorable mix benefits to enterprise gross margin. In the fourth quarter alone, Donaldson paid down $102 million of Facet-related debt, demonstrating strong cash generation and commitment to deleveraging. Net debt to adjusted EBITDA stood at 1.4x at fiscal year-end, up from 0.7x in the prior year due to the acquisition, but on a trajectory toward the company’s target leverage range.
Management highlighted continued investment in technology and organizational capabilities to strengthen long-term profitable growth. The strategic organizational redesign mentioned in the presentation aims to enhance the company’s ability to drive innovation and respond to evolving customer needs across diverse end markets.
Financial Position and Cash Flow
Donaldson’s balance sheet and cash flow performance demonstrated the company’s financial strength and disciplined capital allocation. Adjusted free cash flow conversion reached 136% in the fourth quarter and 91% for the full fiscal year, supported by efficient working capital management.
Cash from operations totaled $200 million in the fourth quarter and $494 million for the full year, representing increases of 19% and 18% respectively versus the prior year. Net capital expenditures of $15 million in the quarter and $57 million for the year reflected disciplined investment in capacity and capabilities while maintaining capital efficiency.
The company’s net debt position increased to $1.074 billion from $488 million in the prior year, primarily due to the Facet acquisition. However, the net debt to adjusted EBITDA ratio of 1.4x remains manageable, and management demonstrated commitment to deleveraging through the $102 million debt paydown in the fourth quarter. Total debt stood at $1.325 billion against cash and cash equivalents of $250 million.
Donaldson returned $37 million to shareholders through dividends in the fourth quarter, with no share repurchases during the period. For the full fiscal year, the company returned $250 million to shareholders through $141 million in dividends and $109 million in share buybacks, demonstrating balanced capital allocation between debt reduction, growth investments, and shareholder returns.
Forward-Looking Statements
Management issued fiscal 2027 guidance projecting continued growth across all segments and further margin expansion. The company expects sales growth of 5.5% to 9.5%, centered on approximately $4.2 billion, with adjusted operating margins ranging from 16.6% to 17.2%.
Diluted earnings per share guidance of $4.22 to $4.38 brackets $4.30 at the midpoint, representing approximately 8% growth from fiscal 2026 adjusted EPS of $3.98. This guidance reflects contributions from organic growth, pricing, the Facet acquisition, and currency benefits, partially offset by integration costs and normal seasonality.
By segment, Mobile Solutions is expected to grow 2% to 6%, with off-road up mid-single digits, on-road up high-single digits, and aftermarket up mid-single digits. Industrial Solutions projects mid-teens growth, with approximately half coming from Facet and the remainder from mid-teens organic growth in Aerospace and Defense and mid-single digit growth in Industrial Filtration Solutions. Life Sciences anticipates 7% to 11% growth, continuing its strong momentum.
The guidance assumes a tax rate of 23.5% to 25.5%, pricing benefit of approximately 2%, Facet sales benefit of approximately 2%, interest expense of $55 million to $60 million, and foreign currency benefit of 1%. Capital expenditures are projected at $70 million to $90 million, with free cash flow conversion of 95% to 105%.
Management noted that the second half of fiscal 2027 should account for approximately 52% of sales and 57% of operating profit, reflecting normal seasonality patterns. The company expects power generation operational issues to improve by mid-fiscal 2027 as production transitions stabilize, providing a tailwind to Industrial Solutions margins in the back half of the year.
The fiscal 2027 outlook represents record guidance for Donaldson, building on the momentum from fiscal 2026 and positioning the company for sustained profitable growth across its diversified portfolio of filtration solutions.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。